466 related articles for article (PubMed ID: 21223417)
1. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
3. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
Kaushic C; Ferreira VH; Kafka JK; Nazli A
Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
Chan T; Barra NG; Lee AJ; Ashkar AA
J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
[TBL] [Abstract][Full Text] [Related]
5. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
7. Mucosal innate immunity as a determinant of HIV susceptibility.
Iqbal SM; Kaul R
Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
[TBL] [Abstract][Full Text] [Related]
8. Role of mucosal immunity in preventing genital herpes infection.
MasCasullo V; Fam E; Keller MJ; Herold BC
Viral Immunol; 2005; 18(4):595-606. PubMed ID: 16359226
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women.
Nazli A; Yao XD; Smieja M; Rosenthal KL; Ashkar AA; Kaushic C
Antiviral Res; 2009 Feb; 81(2):103-12. PubMed ID: 19013198
[TBL] [Abstract][Full Text] [Related]
10. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
Mestecky J
J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors, inflammation and tumor in the human female reproductive tract.
Yu L; Wang L; Chen S
Am J Reprod Immunol; 2009 Jul; 62(1):1-8. PubMed ID: 19527227
[TBL] [Abstract][Full Text] [Related]
13. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
Gill N; Davies EJ; Ashkar AA
Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
[TBL] [Abstract][Full Text] [Related]
14. HIV vaccine and genital secretory immune response.
Stefanache-Guihard AI
Rom J Virol; 1995; 46(1-2):85-98. PubMed ID: 9106405
[TBL] [Abstract][Full Text] [Related]
15. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors, innate immunity and HSV pathogenesis.
Herbst-Kralovetz M; Pyles R
Herpes; 2006 Aug; 13(2):37-41. PubMed ID: 16895653
[TBL] [Abstract][Full Text] [Related]
17. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
Broliden K
J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and chemokines - but not interferon-β - produced in response to HSV-2 in primary human genital epithelial cells are associated with viral replication and the presence of the virion host shutoff protein.
Ferreira VH; Nazli A; Mossman KL; Kaushic C
Am J Reprod Immunol; 2013 Sep; 70(3):199-212. PubMed ID: 23621693
[TBL] [Abstract][Full Text] [Related]
19. Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier.
Nazli A; Dizzell S; Zahoor MA; Ferreira VH; Kafka J; Woods MW; Ouellet M; Ashkar AA; Tremblay MJ; Bowdish DM; Kaushic C
Cell Mol Immunol; 2019 Feb; 16(2):178-194. PubMed ID: 29553138
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.
Ashkar AA; Bauer S; Mitchell WJ; Vieira J; Rosenthal KL
J Virol; 2003 Aug; 77(16):8948-56. PubMed ID: 12885911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
